Tag Archives: 20-20

The NIH’s complicity in faux Bayh-Dole and high drug prices

Posted on June 9, 2017 by Gerald Barnett

Here’s “A ’20-20′ View of Invention Reporting to the National Institutes of Health”–published by the NIH in 1995. 2. WHAT IS THE BAYH-DOLE ACT AND WHY IS IT IMPORTANT? The Bayh-Dole Act encourages researchers to patent and market their inventions … Continue reading →

Posted in Bayh-Dole, History, Stanford v Roche | Tagged , , , , | Comments Off on The NIH’s complicity in faux Bayh-Dole and high drug prices

Why is the 1995 NIH "20-20" Guide Still Up?

Posted on April 14, 2013 by Gerald Barnett

At the University of Cincinnati Intellectual Property web site we find this NIH Guide, the 20 Questions About Extramural Invention Reporting: The Bayh-Dole Act encourages researchers to patent and market their inventions by guaranteeing patent rights. [No, wait–we find the … Continue reading →

Posted in Bayh-Dole, Bozonet, History | Tagged , , , | Comments Off on Why is the 1995 NIH "20-20" Guide Still Up?